What Is an Excipient? Why There Is Mannitol in the Vial
An excipient is an ingredient whose job is something other than being the active substance: it bulks, protects, buffers or preserves. 'Inactive' on a list means it is not the active ingredient, not that it does nothing.
An excipient is any ingredient in a product that is not the active substance. The active substance is the thing the product exists to deliver. An excipient is something else, included for a supporting job such as giving the contents bulk, protecting them, or keeping the liquid at a steady acidity. So when a vial or a leaflet lists something besides the peptide, that second item is almost always an excipient.
The easiest way to picture it is packaging foam inside a delivery box. The foam is not the gift. Nobody opens a parcel hoping for foam. But without it, the gift arrives crushed. Excipients are the foam of a product, and in a freeze-dried peptide vial the most familiar piece of foam is a plain sugar alcohol called mannitol. This article explains what excipients do, why mannitol turns up so often, and why the word 'inactive' is easily misunderstood.
The ingredient that is not the active one
Regulators define the active side of this pairing in a plain way. The United States Food and Drug Administration describes an active ingredient as any component that provides pharmacological activity or other direct effect 2, where pharmacological simply means it acts on the body. Anything else that is deliberately put into the product is, by elimination, something other than the active ingredient. The standard word for it is excipient. The word comes from the Latin for 'to take out' or 'to receive', and it has long been used for a substance that carries or receives the main one.
Notice that the definition is about role, not about identity. The same substance can be an active ingredient in one product and an excipient in another. Mannitol, for instance, is itself used as a medicine in some settings and as a supporting ingredient in many others. What decides the label is the job it does in that particular product.
Because they are everywhere in finished products, there are databases of them. The FDA publishes a downloadable list of the inactive ingredients that appear in approved drug products 3. The existence of such a list shows how routine excipients are: a typical medicine is a short recipe, not a single substance.
What excipients do: bulk, protect, buffer, preserve
There are many individual excipients, but the jobs they do fall into a few simple groups. Four are enough to understand the idea.
| Job | What it means | Everyday comparison |
|---|---|---|
| Bulk | Adds solid material so there is a visible, sturdy structure rather than a trace | Flour added to a tiny pinch of spice so you can see and handle it |
| Protect | Shields a fragile molecule from damage during drying, storage or handling | Foam inside the delivery box |
| Buffer | Keeps the acidity of a liquid steady, because many molecules misbehave if it drifts | A thermostat holding a room at one temperature |
| Preserve | Slows the growth of microorganisms in a product that is used more than once | Salt or vinegar in a jar of pickles |
Not every product needs all four, and not every product uses the same ingredient for the same job. Some excipients do two jobs at once. The detailed engineering of which one goes where is the business of formulation scientists, and it fills technical manuals. For a first look, the useful idea is the one in the table: each excipient is there because it solves a specific problem.
Mannitol in a freeze-dried vial, explained
To see an excipient at work, take the case that prompted the question in the first place: a freeze-dried vial. Freeze-drying, also called lyophilisation, removes water from a frozen liquid so that what remains is a dry solid. A separate article in this series explains the process. What matters here is what is left behind.
Peptides are often needed in very small amounts. If a vial held only the peptide, and that peptide were a fraction of a milligram, the dried remains might be a faint film on the glass, or a few specks, or something that blows around when the vial is moved. It would be hard to see, hard to confirm was present, and fragile. The solid that remains after freeze-drying is usually called a cake, and a good cake is a sturdy, even plug of material.
A bulking agent solves this. Added to the liquid before drying, it forms the body of the cake, with the active ingredient spread through it. Mannitol, which is a sugar alcohol with a faintly sweet taste, is among the most widely used for this. A review in the Journal of Pharmaceutical Sciences describes its physical properties as making it a desirable and preferred bulking agent in comparison with another common choice, glycine 1.
The same review is honest about the difficulties. It notes that mannitol can pose challenges, such as vial breakage during drying, or the fact that it can end up in an unstable crystal form in the finished cake, which means the freeze-drying process has to be designed carefully 1. So a 'plain' excipient turns out to be an engineering decision with its own trade-offs, not a throwaway filler. That is a good place to introduce the next point.
'Inactive' does not mean 'does nothing'
Excipients are commonly called inactive ingredients, and the FDA's own database uses that wording 3. It is a technical label with a narrow meaning: the ingredient is not the one supplying the intended effect. It is not a statement that the ingredient is inert, harmless or unimportant.
Think again about the foam. It is 'inactive' in the sense that it is not the gift. But if you replaced soft foam with sharp gravel, the gift would arrive damaged, and nobody would call the gravel irrelevant. Excipients can affect how stable a product is, how it dissolves, how long it keeps, and how it behaves in an experiment. They are chosen deliberately and tested because they matter.
Because they matter, they are also controlled. Industry bodies publish guidance on how makers should check the quality of excipients and the reliability of the firms that supply them. One such guide from the International Pharmaceutical Excipients Council, updated to a third version in 2026, sets out good practice for qualifying excipient suppliers, and describes the topic as more important than ever given recent cases involving adulterated substances used in making medicines 4. In short, the supporting ingredients are held to quality standards precisely because they can go wrong.
Where excipients are listed and who checks them
For licensed medicines, the answer is straightforward. The full list of ingredients, active and inactive, is part of what a regulator reviews before approval, and it appears in the product information that accompanies it. Changing an excipient is treated as a change to the product, not a casual swap. The reason is the one above: a different supporting ingredient can change how the active one behaves.
This is also why the term appears in discussion of generic products. A copy of a medicine must contain the same active ingredient, but its excipients may differ, and regulators look at whether those differences matter. Separate from all that, it is routine for the lists to be public, which is why a searchable database of inactive ingredients exists at all 3.
Research vials versus licensed medicines: what may be missing
Material sold for laboratory research use only sits outside that system. It has not been through a medicines regulator's review, and there is no requirement that a research label show everything that is in the vial. A label may name only the peptide while the vial also holds a bulking agent. It may name an excipient and say nothing of its amount. It may name neither.
The important point is that the label's silence is not evidence in either direction. It does not show that there is only the peptide in the vial, and it does not show that there is anything else. It simply means the label has not told you. Only a measurement can say what is actually there, and it would have to be a measurement of the right kind: a test of how much peptide is present says nothing about a sugar alcohol alongside it.
Questions to ask when the label lists more than one thing
When a vial or a datasheet names a second ingredient, a handful of plain questions turn the list into information.
- What is each item for? A bulking agent, a protector and a buffer have different jobs, and the label or documentation should make the role clear.
- Is the amount of each stated? A name alone says very little. The proportion matters, because a vial that is mostly excipient by weight is a different thing from one that is mostly active.
- Is the weight on the label the active ingredient alone, or the whole contents? These are not the same, and a number without that distinction can mislead.
- Was the contents list checked by a test, or only asserted? An analysis that confirms the active ingredient does not automatically confirm the rest.
- Is the document consistent with itself? A list that changes between pages is a warning about the care taken in preparing it.
In one sentence
An excipient is the foam in the box: an ingredient that is not the active substance but does a real job, such as the mannitol that gives a freeze-dried vial its body, and 'inactive' on an ingredient list means only that, so the useful question about any extra item is what it is for and how much of it is there.